These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 28316374)

  • 1. The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases.
    Kuwabara T; Ishikawa F; Kondo M; Kakiuchi T
    Mediators Inflamm; 2017; 2017():3908061. PubMed ID: 28316374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of IL-17A in inflammatory immune responses and host defense against pathogens.
    Iwakura Y; Nakae S; Saijo S; Ishigame H
    Immunol Rev; 2008 Dec; 226():57-79. PubMed ID: 19161416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases.
    Yamagata T; Skepner J; Yang J
    Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):405-14. PubMed ID: 26358867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.
    Roeleveld DM; van Nieuwenhuijze AE; van den Berg WB; Koenders MI
    BioDrugs; 2013 Oct; 27(5):439-52. PubMed ID: 23620106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.
    Zhu S; Qian Y
    Clin Sci (Lond); 2012 Jun; 122(11):487-511. PubMed ID: 22324470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis.
    Hirota K; Hashimoto M; Yoshitomi H; Tanaka S; Nomura T; Yamaguchi T; Iwakura Y; Sakaguchi N; Sakaguchi S
    J Exp Med; 2007 Jan; 204(1):41-7. PubMed ID: 17227914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited.
    Boniface K; Blom B; Liu YJ; de Waal Malefyt R
    Immunol Rev; 2008 Dec; 226():132-46. PubMed ID: 19161421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diseases that may benefit from manipulating the Th17 pathway.
    Miossec P
    Eur J Immunol; 2009 Mar; 39(3):667-9. PubMed ID: 19283719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
    Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
    Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innately versatile: γδ17 T cells in inflammatory and autoimmune diseases.
    Papotto PH; Reinhardt A; Prinz I; Silva-Santos B
    J Autoimmun; 2018 Feb; 87():26-37. PubMed ID: 29203226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-17-producing T cells in lung immunity and inflammation.
    Nembrini C; Marsland BJ; Kopf M
    J Allergy Clin Immunol; 2009 May; 123(5):986-94; quiz 995-6. PubMed ID: 19410688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases.
    Qu N; Xu M; Mizoguchi I; Furusawa J; Kaneko K; Watanabe K; Mizuguchi J; Itoh M; Kawakami Y; Yoshimoto T
    Clin Dev Immunol; 2013; 2013():968549. PubMed ID: 23956763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-17 as a drug target in human disease.
    Ivanov S; Lindén A
    Trends Pharmacol Sci; 2009 Feb; 30(2):95-103. PubMed ID: 19162337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-12 family members and type I interferons in Th17-mediated inflammatory disorders.
    Goriely S; Cavoy R; Goldman M
    Allergy; 2009 May; 64(5):702-9. PubMed ID: 19383026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Th17 cells in autoimmune diseases.
    Yang J; Sundrud MS; Skepner J; Yamagata T
    Trends Pharmacol Sci; 2014 Oct; 35(10):493-500. PubMed ID: 25131183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenicity of Th17 cells in autoimmune diseases.
    Yasuda K; Takeuchi Y; Hirota K
    Semin Immunopathol; 2019 May; 41(3):283-297. PubMed ID: 30891627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-37 Alleviates Rheumatoid Arthritis by Suppressing IL-17 and IL-17-Triggering Cytokine Production and Limiting Th17 Cell Proliferation.
    Ye L; Jiang B; Deng J; Du J; Xiong W; Guan Y; Wen Z; Huang K; Huang Z
    J Immunol; 2015 Jun; 194(11):5110-9. PubMed ID: 25917106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis.
    Astry B; Harberts E; Moudgil KD
    J Interferon Cytokine Res; 2011 Dec; 31(12):927-40. PubMed ID: 22149412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of interleukin-17A in psoriatic disease.
    Adami S; Cavani A; Rossi F; Girolomoni G
    BioDrugs; 2014 Dec; 28(6):487-97. PubMed ID: 24890029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.